MAIOLINO, GIUSEPPE
 Distribuzione geografica
Continente #
NA - Nord America 4.449
EU - Europa 535
AS - Asia 501
OC - Oceania 2
SA - Sud America 2
Totale 5.489
Nazione #
US - Stati Uniti d'America 4.446
CN - Cina 257
SG - Singapore 180
IT - Italia 178
SE - Svezia 110
FI - Finlandia 63
GB - Regno Unito 49
DE - Germania 42
VN - Vietnam 36
FR - Francia 35
UA - Ucraina 28
IN - India 21
NL - Olanda 7
IE - Irlanda 6
AT - Austria 4
HK - Hong Kong 3
SI - Slovenia 3
BG - Bulgaria 2
CA - Canada 2
MY - Malesia 2
PE - Perù 2
RU - Federazione Russa 2
AU - Australia 1
CH - Svizzera 1
DK - Danimarca 1
HU - Ungheria 1
IQ - Iraq 1
KR - Corea 1
MX - Messico 1
NZ - Nuova Zelanda 1
PL - Polonia 1
PT - Portogallo 1
RS - Serbia 1
Totale 5.489
Città #
Fairfield 885
Woodbridge 454
Chandler 361
Houston 339
Ashburn 336
Seattle 317
Ann Arbor 296
Cambridge 268
Wilmington 266
Singapore 130
Jacksonville 97
Princeton 81
San Diego 76
Padova 71
Boardman 57
Medford 57
Beijing 53
Roxbury 53
Des Moines 44
Nanjing 37
Dong Ket 35
Helsinki 34
Santa Clara 30
New York 28
Jinan 19
Guangzhou 16
London 12
Hebei 10
Shenyang 9
Changsha 7
Jiaxing 7
Nanchang 7
Redwood City 7
Cagliari 6
Hangzhou 6
Milan 6
Dublin 5
Kunming 5
Lanzhou 5
Rome 5
Baotou 4
Norwalk 4
Shanghai 4
Bussero 3
Huizen 3
Islington 3
Kharkiv 3
Naples 3
San Jose 3
Tianjin 3
Zhengzhou 3
Baiano 2
Bergamo 2
Brescia 2
Charleston 2
Chongqing 2
Fuzhou 2
Hefei 2
Kuala Lumpur 2
Lima 2
Ogden 2
Orange 2
Paris 2
Prescot 2
Quzhou 2
Rockville 2
Sofia 2
Taizhou 2
Trento 2
Vienna 2
Villorba 2
Acton 1
Auckland 1
Belgrade 1
Borås 1
Bottanuco 1
Brendola 1
Bristol 1
Budapest 1
Buffalo 1
Böblingen 1
Cardiff 1
Castelfranco Veneto 1
Castelnuovo di Val di Cecina 1
Chiswick 1
Dearborn 1
Derry 1
Dongguan 1
Esslingen am Neckar 1
Falkenstein 1
Falls Church 1
Frankfurt am Main 1
Gunzenhausen 1
Indiana 1
Irkutsk 1
Kherson 1
Kilburn 1
Kongens Lyngby 1
Las Vegas 1
Lisbon 1
Totale 4.642
Nome #
PTH Modulation by Aldosterone and Angiotensin II is Blunted in Hyperaldosteronism and Rescued by Adrenalectomy 278
Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study 169
Galectin-3 predicts long-term cardiovascular death in high-risk patients with coronary artery disease. 143
The Intra-Procedural Cortisol Assay During Adrenal Vein Sampling: Rationale and Design of a Randomized Study (I-Padua) 140
A sleep apnoea questionnaire predicts organ damage in hypertensive patients 139
Design of a study to investigate the mechanisms of obstructive sleep apnoea by means of drug-induced sleep endoscopy 134
Proinflammatory/profibrotic effects of aldosterone in Gitelman’s syndrome, a human model opposite to hypertension 127
Macrolides for KCNJ5–mutated aldosterone-producing adenoma (MAPA): design of a study for personalized diagnosis of primary aldosteronism 117
Assessment of the Quantitative Value Usefulness of the Aldosterone-Renin Ratio (ARR) for Primary Aldosteronism (AQUARR) Study 116
Lipoprotein-associated phospholipase A2 activity predicts cardiovascular events in high risk coronary artery disease patients. 114
Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women 112
Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term 107
Hyperhomocysteinemia predicts total and cardiovascular mortality in high-risk women. 106
Daily green tea extract supplementation reduces prothrombotic and inflammatory states in dialysis patients 106
Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone–renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design 105
A meta-analysis of somatic KCNJ5 K+ channel mutations in 1636 patients with an aldosterone-producing adenoma 102
Effect of olmesartan medoxomil on number and survival of circulating endothelial progenitor cells and calcitonin gene related peptide in hypertensive patients. 101
Antibodies to malondialdehyde oxidized low-density lipoproteins predict long term cardiovascular mortality in high risk patients. 101
Under treatment with lipid-lowering drugs of high-risk coronary heart disease patients of the GENICA study 100
Subtyping of primary aldosteronism with adrenal vein sampling: Hormone- and side-specific effects of cosyntropin and metoclopramide 97
High sodium intake, glomerular hyperfiltration, and protein catabolism in patients with essential hypertension. 96
Gαq/p63RhoGEF interaction in RhoA/Rho kinase signaling: investigation in Gitelman’s syndrome and implications with hypertension 94
Relationship of early carotid artery disease with lipoprotein (a), apolipoprotein B, and fibrinogen in asymptomatic essential hypertensive patients and normotensive subjects 91
Oxidative stress and the altered reaction to it in Fabry disease: A possible target for cardiovascular-renal remodeling? 90
The Time has Come for Systematic Screening for Primary Aldosteronism in All Hypertensives 89
Increased level of p63RhoGEF and RhoA/Rho kinase activity in hypertensive patients 89
In Patients with Chronic Kidney Disease Short Term Blood Pressure Variability is Associated with the Presence and Severity of Sleep Disorders 88
Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high-risk coronary artery disease hypertensives 87
Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble 87
The T-786 C endothelial nitric oxide synthase genotype is a novel risk factor for coronary artery disease in caucasian patients of the GENICA study 85
Cure with cryoablation of arterial hypertension due to a renin-producing tumor. 85
Atrial fibrillation as presenting sign of primary aldosteronism: Results of the Prospective Appraisal on the Prevalence of Primary Aldosteronism in Hypertensive (PAPPHY) Study 79
The Molecular Basis of the Interplay between Endothelin-1 and Nitric Oxide and its Relevance for Atherosclerosis and Arterial and Pulmonary Hypertension. 76
To reconsider (limit) the use of phosphate based food and beverages additives. A real need for health preservation. 75
Antibodies to oxidized low-density lipoproteins and angiographically assessed coronary artery disease in white patients 75
Uric acid and cardiovascular-renal disease risk. Insights from a human model opposite to hypertension 71
Subtyping of Primary Aldosteronism in the AVIS-2 Study: Assessment of Selectivity and Lateralization 71
Lipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complications. 70
Resolution of Drug-Resistant Hypertension by Adrenal Vein Sampling-guided Adrenalectomy: A Proof-of-Concept Study 70
Is there an increased heme oxygenase-1 behind the antioxidant effects of green tea on blood pressure and sympathoexcitation reduction? 69
The subtyping of primary aldosteronism by adrenal vein sampling: Sequential blood sampling causes factitious lateralization 69
Oxidative stress in hypertension and cardiovascular-renal remodeling:focus on the renin-angiotensin-aldosterone system 68
Androstenedione and 17-α-Hydroxyprogesterone Are Better Indicators of Adrenal Vein Sampling Selectivity Than Cortisol 67
Practice Recommendations for Diagnosis and Treatment of the Most Common Forms of Secondary Hypertension 67
LB02.07: EFFECT OF ACUTE DA2 DOPAMINERGIC RECEPTOR BLOCKADE ON PERFORMANCE OF ADRENAL VEIN SAMPLING FOR SUBTYPING OF PRIMARY ALDOSTERONISM 64
New insights on the renal protective effects of mineralocorticoid receptor antagonists. 61
Macrolides Blunt Aldosterone Biosynthesis: A Proof-of-Concept Study in KCNJ5 Mutated Adenoma Cells Ex Vivo 60
Recent advances in the diagnosis and management of obstructive sleep apnea 57
Adrenal Venous Sampling: Where Do We Stand? 57
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism 56
-786C and G894T variants of the Endothelial Nitric Oxide Synthase Gene and training-induced correction of endothelial dysfunction in coronary artery disease patients. 55
Magnesium, cardiovascular-renal disease and the Gitelman's syndrome paradox. 55
Primary aldosteronism in elderly, old, and very old patients 55
Comparative study at computed tomography angiography and intravascular ultrasound of coronary atherosclerotic plaques 54
Survival and rehospitalization in patients with severe ischemic mitral regurgitation and multivessel coronary artery disease undergoing different treatment 53
Mineralocorticoid Receptor Antagonists Therapy in Resistant Hypertension: Time to Implement Guidelines! 52
The cardiovascular consequences of hyperaldosteronism 50
Metoclopramide unmasks potentially misleading contralateral suppression in patients undergoing adrenal vein sampling for primary aldosteronism 46
Arterial Hypertension, Aldosterone, and Atrial Fibrillation 44
Moderate-to-severe ischeamic mitral regurgitation and multivessel coronary artery disease: impact of different treatment on survival and rehospitalization 43
Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study 42
Effects of insomnia and restless legs syndrome on sleep arterial blood pressure: A systematic review and meta-analysis 39
The role of oxidized low-density lipoproteins in atherosclerosis: The myths and the facts 38
Excessive daytime sleepiness does not correlate with sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea: A proof-of-principle study 37
The Molecular Basis of the Interplay Interventional approach to reduce thromboembolic risk in patients with atrial fibrillation ineligible for oral anticoagulation 35
Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure 35
Excess arterial damage in hyperaldosteronism: Further evidence from pressure wave analysis 32
Excessive daytime sleepiness, sympathetic nervous system activation and arterial stiffening in patients with mild-to-moderate obstructive sleep apnoea. Reply 24
International multicenter survey on screening and confirmatory testing in primary aldosteronism 10
Totale 5.576
Categoria #
all - tutte 20.660
article - articoli 19.948
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 263
Totale 40.871


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020905 0 0 0 0 141 78 151 128 168 99 90 50
2020/20211.185 44 70 43 87 33 40 87 86 120 300 99 176
2021/2022959 13 90 88 83 92 79 51 102 53 25 73 210
2022/2023708 142 82 26 81 104 84 6 52 86 13 25 7
2023/2024327 18 43 51 29 16 41 22 16 8 15 26 42
2024/2025296 9 106 87 61 33 0 0 0 0 0 0 0
Totale 5.576